![](https://images.squarespace-cdn.com/content/v1/65a911827319774b11de6f1c/ad7f7d7c-4907-4090-86fb-ffe8bc848d62/shutterstock_1968439885.jpg)
Patients
Our goal is to develop transformative cures for complex diseases
For patients, caregivers, loved ones, advocates & healthcare specialists
At Alyssum, we recognize that patients with cancer and immune diseases are in desperate need of highly effective innovative therapies. We strive to advance next-generation targeted immunotherapies with the potential to improve patient outcomes and quality of life.
We are actively recruiting patients to participate in clinical trials to evaluate our therapeutic candidates. If you believe you or a loved one might be a good candidate for our trials, we encourage you to reach out directly through the link provided.
Currently ongoing clinical studies
A Phase 1/2 study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of AT-1965 in patients with advanced, refractory or recurrent solid tumors.
Enroll for Trial